The Anglo-Scandinavian Cardiac Outcomes Trial – Blood Pressure Lowering Arm (ASCOT-BPLA) Blood Pressure Variability and Cardiovascular Outcomes PS Sever,
B.Dahlof (Co-chair), P.Sever (Co-chair), N. Poulter (Secretary) H. Wedel (Statistician), G. Beevers, M. Caulfield, R. Collins S. Kjeldsen, A. Kristinsson,
EFIM 2013 Final Programme 19.9.
NICE Coronary heart disease
Holistik papdi by prof dr.jose rosma
EFIM 2013 Final Scientific Programme 23.9.
Physical Activity and Cardiovascular Disease ANDREAS PITTARAS MD.
Controversial comments ~ HERS 1996 ~ WHI 2002-2003 ~ MWS2003-2004 ~ « witch-hunt » ~ back to reasonable, adequate analyses, experience…
Dyslipidemia: What Every Resident Should Know. Med Study Lipoproteins –Chylomicrons, VLDL, IDL, LDL, & HDL Hyperlipoproteinemia –Familial syndromes Evaluation.
James Hoey & George Ingram. Coronary Heart Disease (CHD) is well documented as the single largest cause of death in the Western world and is more likely.
Gene Polymorphisms and Coronary Heart Disease Fang Zheng Clinic Lab, Zhongnan Hospital, Wuhan University.
The use of progestins today